Alector has completed subject enrolment in the 76-week, randomised, Phase II PROGRESS-AD trial, which is assessing the ...

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...

GSK (GSK) announced that the US CDC’s Advisory Committee on Immunization Practices has voted to recommend use of Penmvevy as part of the ...

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

CEO Emma Walmsley said the company has been anticipating tariffs on the industry and is “confident” the company can navigate through it, Ashleigh Furlong and Ruth David of Bloomberg reports. The U.S.

Only 40 per cent of the total CEO compensation components is fixed and the remaining 60 per cent is at risk. Short-term incentives or annual bonuses comprise 25 per cent of total CEO compensation ...

Ohio Attorney General Dave Yost is pushing to take a leading role in a federal securities lawsuit that accuses pharmaceutical ...

While there’s more detail to surface on the tragic killing of Austin Metcalf, Karmelo Anthony is getting wide support from people. The CEO of a financial services company has recently opened up ...

Sam White, a CEO, said hangovers from her weekends made her "tired and groggy" on Mondays. White decided to get sober in 2022. She said she now has more energy, is more resilient, and performs ...

Amid the current market turmoil, it is worth remembering that the pharmaceutical industry must continue its normal business of ensuring that it has products to sell in 10 years, with GSK (GSK) signing ...

In the release, the biotech’s CEO Sang Hoon Lee said the agreement with GSK “will serve as a great opportunity to strengthen ABL Bio's position in the neurodegenerative disease treatment ...

ABL Bio Inc. announced April 7 that it sealed a potential £2.075 billion (US$2.65 billion) license deal with GSK plc, granting GSK global rights to use ABL’s blood-brain barrier (BBB) penetrating ...